Shilpa Medicare Ltd. NSE: SHILPAMED | BSE: 530549

Mid-range Performer

Download real time

846.25 3.45 (0.41%)

52.48% Gain from 52W Low

52,909

NSE+BSE Volume

NSE 29 Aug, 2025 3:31 PM (IST)

Dividend

Shilpa Medicare Ltd. has an upcoming dividend of ₹1.00 per share due on 17 Sep 2025 See details

Shilpa Medicare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shilpa Medicare Ltd. on BSE

Load latest

Shilpa Medicare Ltd.

23 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Shilpa Biocare, A Wholly Owned Subsidiary Of Shilpa Medicare Enters …

BSE India

Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare enters into a strategic partnership with Orion Corporation ("Orion"), Finland.

Shilpa Medicare Ltd.

20 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Change Of Statutory Auditors Firm Name

BSE India

Change of Statutory Auditors firm name

Shilpa Medicare Ltd.

19 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Q4 FY25 Earnings Conference Call, which is to be held on Monday, May 26, 2025, at 17.00 hrs.

Shilpa Medicare Ltd.

19 May 2025

846.25

0.41%

Board Meeting

Shilpa Medicare Ltd - 530549 - Board Meeting Intimation for Consideration Of Audited Financial Statements (Consolidated …

BSE India

Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve (a) audited financial statements (Consolidated & Standalone) for the financial year ending March 31, 2025. (b) audited financial results (Consolidated & Standalone) for the quarter and financial year ending March 31, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (c ) recommendation of dividend, if any for the Financial Year 2024-25.

Shilpa Medicare Ltd.

14 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Announcement Under Regulation 30 Of The SEBI(LODR) Regulations

BSE India

Shilpa Pharma Lifesciences Limited, Unit -1 Received EIR from USFDA.

Shilpa Medicare Ltd.

06 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Approval by European Medicines Agency, for Shilpa Medicare Limited Unit VI, Bengaluru.

Shilpa Medicare Ltd.

03 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Revised Announcement Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Europe (AGES, Austria) Inspection of Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited

Shilpa Medicare Ltd.

03 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Europe(AGES, Austria) Inspection of Shilpa Biologicals Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited

Shilpa Medicare Ltd.

03 May 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Europe(AGES, Austria) Inspection of Shilpa Biologicals Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited

Shilpa Medicare Ltd.

17 Apr 2025

846.25

0.41%

Company Update

Shilpa Medicare Ltd - 530549 - Celltrion Arbitral Award

BSE India

Celltrion Arbitral Award

Is Shilpa Medicare Ltd. worth buying?

246 Votes:

Buy 78.86%

Sell 11.79%

Hold 9.35%